Title:Nanomedicine as a Better Therapeutic Approach: An Overview
Volume: 14
Issue: 3
Author(s): Arnab Das and Srijita Chakrabarti*
Affiliation:
- Himalayan Pharmacy Institute, Majhitar, Sikkim-737136, India
Keywords:
Cancer, CNS Diseases, CVS Diseases, nanomedicine, pharmaceutical, targeted drug delivery.
Abstract: The fields of nanotechnology and nanomedicine have undergone a revolution. There
has been a striking rise in authorized nanomedicines since 1980. Apart from functioning as therapeutic
agents, they also act as carriers for delivering various active pharmaceuticals to target organs.
The ultimate goal of nanomedicine has always been the generation of translational technologies
that can improve current therapies. Nanocrystals, nanotubes, liposomes, exosomes, solid lipid
nanoparticles, polymeric nanoparticles, and metallic and magnetic nanoparticles are examples
of nanostructures that are now in the market as well as in ongoing research. The preparation of
these nanomaterials requires consideration of a number of difficulties. Only a few of these nanomaterials
were successful in obtaining marketing permission after passing all required toxicological
and ethical evaluations and making them affordable to users and, at the same time, profitable
to investors. Cancer, central nervous system (CNS) diseases, and cardiovascular (CVS) diseases
represented the primary targets of nanotechnology applied to medicine. Therefore, this review article
is focused on providing a summary of several nano-based delivery systems, including their
limitations and prospects in different therapeutic fields.
